- Home
- PCB vs RLMD Comparison
PCB vs RLMD Comparison
Compare PCB & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCB | RLMD |
|---|---|---|
| Founded | 2003 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 313.0M | 319.7M |
| IPO Year | 2018 | 2012 |
Fundamental Metrics
Financial Performance| Metric | PCB | RLMD |
|---|---|---|
| Price | $22.02 | $6.05 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $24.50 | $10.25 |
| AVG Volume (30 Days) | 19.1K | ★ 542.6K |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.00% | N/A |
| EPS Growth | N/A | ★ 19.21 |
| EPS | ★ 1.94 | N/A |
| Revenue | ★ $2,774,000.00 | $13,070.00 |
| Revenue This Year | $13.73 | N/A |
| Revenue Next Year | $9.07 | N/A |
| P/E Ratio | $11.35 | ★ N/A |
| Revenue Growth | 4.68 | ★ 154.83 |
| 52 Week Low | $16.02 | $0.24 |
| 52 Week High | $24.20 | $5.12 |
Technical Indicators
Market Signals| Indicator | PCB | RLMD |
|---|---|---|
| Relative Strength Index (RSI) | 39.15 | 73.45 |
| Support Level | $21.12 | $3.49 |
| Resistance Level | $22.30 | N/A |
| Average True Range (ATR) | 0.69 | 0.38 |
| MACD | -0.13 | 0.12 |
| Stochastic Oscillator | 25.86 | 97.21 |
Price Performance
Historical ComparisonAbout PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.